Stephanie Finzel - Department of Rheumatology and Clinical Immunology, University of Freiburg

基本信息

浏览量：35

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 220 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Iscalimab (CFZ533) in Patients with Sjögren Disease: Week 24 Efficacy and Safety Results of a Randomized, Placebo-Controlled, Phase 2b Dose-Ranging Study

Thomas Grader-Beck,Benjamin A. Fisher,Xavier Mariette,Athena Papas,Hendrika Bootsma, Wan-Fai Ng,P.L.A. Van Daele,Stephanie Finzel, Sergio Elgueta,Josef Hermann,Sara S. McCoy,Arthur Bookman,Monika Sopala,Wen-Lin Luo, Cornelia Scheurer,Wolfgang Hueber

Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiologyno. 2 (2025): e50

引用0浏览0引用

Scoping Literature Review to Identify Candidate Domains for the OMERACT Systemic Lupus Erythematosus Core Outcome Set

Wils Nielsen, Fadi Kharouf, Carolina Munoz Grajales, Aarabi Thayaparan,Melanie Anderson,Vibeke Strand, Lee Simon, Dennisse Bonilla,Eric Morand,Julian Thumboo,Martin Aringer,Marta Mosca,Ian Bruce, Elektra J Papadopoulos,Karina D Torralba, Laura Patricia Whitall-Garcia,Cheryl F Rosen,Ioannis Parodis, Alfred Kim, Maya Desai, Yvonne Enman,Beverley Shea,Daniel J Wallace,Yashaar Chaichian,Sandra Navarra,Cynthia Aranow,Meggan Mackay,Kimberly Trotter,Oshrat E Tayer-Shifman,Alí Duarte-García,Lai Shan Tam, Manuel F Ugarte-Gil,Guillermo J Pons-Estel,John A Reynolds,Mandana Nikpour,Alberta Hoi,Juanita Romero-Diaz,Amita Aggarwal, Danaë Papachristos,Chi Chiu Mok,Keishi Fujio,Rosalind Ramsey-Goldman,Alexandra Legge,Laurent Arnaud,Irene E M Bultink,Stephanie Finzel,Reinhard E Voll,Guillermo Ruiz-Irastorza, Luís Sousa Inês,Simone Appenzeller,Chrisanna Dobrowolski, Ann Elaine Clarke,Diane L Kamen,Michelle Barraclough,Chiara Tani,Jose A Gómez-Puerta,Victoria P Werth,Patti Katz, Anca D Askanase,Kathleen Bingham,Dafna D Gladman,Sindhu Johnson,Aaron Drucker, Behdin Nowrouzi-Kia,Zahi Touma, OMERACT SLE Working Group

Seminars in arthritis and rheumatism（2025）

引用0浏览0WOS引用

Efficacité Et Sécurité De L’iscalimab (un AcM Anti-Cd40) Chez Les Patients Atteints De Maladie De Sjögren : Résultats À 48 Semaines D’un Essai De Phase 2b, Randomisé Et Contrôlé Par Placebo (TWINSS)

X. Mariette,B. Fisher,A. Papas, T. Grader-Beck,H. Bootsma,W.F. Ng,P. La Van Daele,S. Finzel, S. Elgueta,J. Hermann,S.S. Mccoy,A. Bookman,M. Sopala,E. Hua, L. Chen, C. Scheurer,W. Hueber

La Revue de Médecine Interne (2024): A58-A59

引用0浏览0引用

Macrophage Colony-Stimulating Factor Receptor/cd115+ Non-Classical Monocytes Are Expanded in Systemic Lupus Erythematosus and Associated with Lupus Nephritis

M. Zeisbrich,R. Rzepka,S. Finzel,N. Venhoff,R. E. Voll

SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2024)

引用0浏览0WOS引用

POS0375 ASSESSMENT OF S95011 (OSE-127, LUSVERTIKIMAB), AN ANTI-INTERLEUKIN 7 RECEPTOR MONOCLONAL ANTIBODY, IN PATIENTS WITH PRIMARY SJÖGREN’S SYNDROME: AN INTERNATIONAL MULTICENTRE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2A STUDY

Fisher B.,Szántó A., Rischmueller M., Varga T.,Kleyer A.,Finzel S., Garcia Meijide J.A., Sánchez-Bursón J., Galtier S., Sandré C.,Mariette X.

Annals of the Rheumatic Diseases (2024): 362-363

引用0浏览0引用

OP0089 PHASE 2 SAFETY AND EFFICACY OF SUBCUTANEOUS (S.C.) DOSE IANALUMAB (VAY736; ANTI-BAFFR Mab) ADMINISTERED EVERY 4 WEEKS UP TO 48 WEEKS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)

Agmon-Levin N., Ignatenko S., Gordienko A.,Cortés-Hernández J.,Narongroeknawin P.,Romanowska -Prochnicka K.,Shen N.,Ciferská H., Kodera M.,Wei J.C.C.,Leszczynski P.,Lan J.L.,Mysler E.,Wojciechowski R.,Tarr T.,Vishneva E.,Chen Y.H., Kaneko Y.,Finzel S.,Hoi A.

Annals of the Rheumatic Diseases (2024): 140-142

引用0浏览0引用

Immunpathogenese des systemischen Lupus erythematodes

Martin Aringer,Stephanie Finzel,Reinhard E. Voll

Zeitschrift für Rheumatologie（2024）

引用3浏览0引用

Modulation Dose-Dépendante Des Signatures Protéomiques Par Le Ianalumab Chez Les Patients Atteints De La Maladie De Sjögren

X. Mariette,G.M. Verstappen,H. Bootsma,S. Finzel, A. Grioni,B. Fisher,A. Papas, R. Celine,A. Avrameas, D. Tuckwell, J. Zierer,V. De Luca,E. Ferrero, C. Bonal, A. Dacosta, R. Hillenbrand, I. Isnardi,W. Hueber

La Revue de Médecine Interne (2024): A56-A57

引用0浏览0引用

OP0008 SAFETY AND EFFICACY OF ISCALIMAB IN PATIENTS WITH SJÖGREN’S DISEASE: 48-WEEK RESULTS FROM A RANDOMISED, PLACEBO-CONTROLLED, PHASE 2B DOSE-RANGING TRIAL

Mariette X.,Fisher B.,Papas A., Grader-Beck T.,Bootsma H., Ng W.F.,Van Daele P.L.,Finzel S., Elgueta S.,Hermann J.,Mccoy S.S.,Bookman A.,Sopala M.,Hua E., Chen L., Scheurer C.,Hueber W.

Annals of the Rheumatic Diseases (2024): 124-125

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn